← all works
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Management of metastatic bone disease
- Field
- Medicine
- Canadian institutions
- Nova Scotia Cancer CentreMcGill University Health CentreJuravinski Cancer CentreSurrey Place CentrePositive Living NorthLondon Health Sciences Centre
- Funders
- Ontario Institute for Cancer Research
- Keywords
- SABR volatility modelAblative caseMedicineRadiation therapyStandard of careOpen labelPalliative careRadiosurgeryRandomized controlled trialSurgery
- Has abstract in OpenAlex
- no